interferon beta-1a IM
Selected indexed studies
- Interferon beta 1a. (Baillieres Clin Neurol, 1997) [PMID:10101585]
- Weekly IM interferon beta-1a in multiple sclerosis patients over 50 years of age. (Eur J Neurol, 2012) [PMID:21718390]
- Interferon beta-1a sc at 25 years: a mainstay in the treatment of multiple sclerosis over the period of one generation. (Expert Rev Clin Immunol, 2023) [PMID:37694381]
_Worker-drafted node — pending editorial review._
Connections
No connections recorded yet.
Sources
- Interferon beta-1a sc at 25 years: a mainstay in the treatment of multiple sclerosis over the period of one generation. (2023) pubmed
- Interferon beta 1a. (1997) pubmed
- Subcutaneous interferon-beta-1a : new formulation. (2007) pubmed
- Weekly IM interferon beta-1a in multiple sclerosis patients over 50 years of age. (2012) pubmed
- Interferon Beta-1a versus Glatiramer Acetate: Changes of Innate Immunity in a Group of Women with Multiple Sclerosis. (2023) pubmed
- Interferon Beta-1a treatment promotes SARS-CoV-2 mRNA vaccine response in multiple sclerosis subjects. (2022) pubmed
- Lack of Clinical Benefit of Interferon β-1a Among Patients With Severe Acute Respiratory Distress Syndrome: Time to Overhaul Drug Trials in ARDS? (2020) pubmed
- Gender effects on intramuscular interferon beta-1a in relapsing-remitting multiple sclerosis: analysis of 1406 patients. (2011) pubmed
- [Interferon beta-1a]. (2004) pubmed
- Interferon β-1a and Atorvastatin in the Treatment of Multiple Sclerosis. (2016) pubmed